Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04974307
Other study ID # 10000414
Secondary ID 000414-CH
Status Completed
Phase N/A
First received
Last updated
Start date September 30, 2021
Est. completion date October 7, 2023

Study information

Verified date February 23, 2024
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: CLN3 involves vision loss observed around the preschool years, with eventual progression to blindness within 1-3 years. Researchers want to test an assistive device that may help children with CLN3 or blindness. Objective: To learn if it is safe, easy, and useful for children with CLN3 or blindness to use the OrCam. Eligibility: People aged 6-18 years who have either CLN3-related disease or blindness. Design: Participants will be screened with the following: Medical history Physical exam Family history Eye exam and vision tests. They will get eyedrops to dilate their eyes. Psychological and neurocognitive tests. They will be asked questions and observed for how they do various tasks, such as talking, playing, writing, drawing, and solving problems. Hearing tests. They may wear headphones or earplugs. Electrodes may be taped to their head. Blood samples Skin biopsy, if needed Cheek cell, saliva, or urine samples The OrCam is the size of and weighs about half as much as a pack of gum. It is attached to eyeglass frames by magnets. Participants will do tasks before and after they have been trained on the OrCam. They will do these tasks without or with using the OrCam. Participants will be given an OrCam to use for 1 week or 1 month. They will have check-in sessions with the study team. Participants and/or their caregivers will be asked about abilities, behaviors, social skills, learning methods, intelligence, and health-related quality of life. Participants samples may be used for genetic testing and/or to make a type of stem cell. Participation will last for 1-5 weeks.


Description:

Study Description: This is a pilot study of an augmentative visual device, OrCam MyEye 2 (OrCam), in pediatric individuals with CLN3-related conditions or low vision. We hypothesize that, given the relatively simple design and operating procedure of the device, the use of the OrCam by study participants will be safe and feasible. We also hypothesize that the device will enhance their ability to obtain visually based information. Objectives: Primary: Assess the safety and feasibility of OrCam use by children with CLN3 or low vision. Secondary: Assess the effectiveness of OrCam use by children with CLN3 or low vision. Exploratory: Assess the feasibility and effectiveness of OrCam use in CLN3 versus non-CLN3 groups. Optimize methods for assessing efficacy of visual accommodation/assistive devices for the CLN3/NCL population Endpoints: Primary: 1) Adverse events during the use of OrCam. 2) Feasibility test. 3) Feasibility questionnaire. 4) Device use diary. The assessment periods will be 1 week at study site and 1 month at home. Secondary: 1) Function test of using OrCam. 2) Ability questionnaire. Exploratory: 1) Function test. 2) Feasibility, Ability, Applicability questionnaires.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date October 7, 2023
Est. primary completion date October 6, 2023
Accepts healthy volunteers No
Gender All
Age group 6 Years to 18 Years
Eligibility - INCLUSION CRITERIA: To participate in the screening portion of this study, an individual must meet all of the following criteria: -Has a diagnosis or suspected diagnosis of any genetically based condition causing low vision to the level specified in criteria 2. If the genetic condition is CLN3-related, the individual must have one of the following: - Two CLN3 pathogenic variants, - One CLN3 pathogenic variant AND - clinical presentation suggestive of CLN3, OR - characteristic electron microscopy (EM) findings (such as curvilinear body, fingerprint profile, granular osmiophilic deposits). - Has an estimated visual acuity in the better seeing eye < 20/200, without the use of an assistive or augmentative device. - Is between 6 to 18 years of age. - To participate in the intervention/device use portion of this study, an individual must meet the above screening criteria and the following criteria: - Has an appropriate cognitive developmental ability to participate based on Investigators screening assessment. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: - Has any of the following auditory dysfunctions: non-reversible or non-correctable hearing loss, tinnitus that is chronic or occurring daily, auditory hallucinations that occur daily. - Uses an optic-to-audio assistive device at the time or within 3 months of screening and enrollment. - Is unable to travel to the NIH because of medical condition for required in-person portions of the study. - Is unable to comply with or have medical conditions that would potentially increase the risk of participation.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
OrCam MyEye 2
The study uses the OrCam MyEye 2, a 22.5-g portable, eyeglass-mounted device that converts camera-captured inputs to auditory outputs. Its advertised functions include text reading, facial recognition, and product identification. The study participants and parents/guardians will be trained on how to use the device. Evaluations for primary and secondary endpoints will be done following 1 week and 1 month of device use.

Locations

Country Name City State
United States National Institutes of Health Clinical Center Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To assess: a) safety and b) feasibility of using OrCam MyEye 2 by children with CLN3 or low vision a) Adverse events; b) Feasibility test, Feasibility questionnaire, and Device use diary 1 week, 1 month
Secondary To assess the efficacy of using the OrCam by children with CLN3 or low vision 1) Function Test - Efficacy Scores; 2) Ability questionnaire 1 week, 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT04929756 - Eye Movement Rehabilitation in Low Vision Patients
Completed NCT02310880 - Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World N/A
Terminated NCT04040790 - Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris N/A
Recruiting NCT06107881 - Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision N/A
Completed NCT00545220 - Problem Solving Training and Low Vision Rehabilitation N/A
Recruiting NCT04066075 - Beacon Sensors and Telerehabilitation for Low Vision N/A
Recruiting NCT04281732 - Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision
Completed NCT01217502 - Self-management for Dual Sensory Impaired N/A
Completed NCT00946062 - Evaluation of a Standardised Orientation and Mobility Training in Older Adults With Low Vision N/A
Terminated NCT04276610 - Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning? N/A
Recruiting NCT05829135 - Improving Glare and Visual Comfort for Patients With Visual Impairment N/A
Completed NCT04242836 - Development and Validation of a Digital Optotype for Near Vision in Greek Language.
Terminated NCT03353727 - Orthoptic Rehabilitation for Low Vision People With Innovative Mechanisms (Eye Tracker and Tactile Device) N/A
Completed NCT04926974 - Community Access Through Remote Eyesight (CARE) Study N/A
Completed NCT00348621 - A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents Phase 4
Not yet recruiting NCT03104608 - Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD) N/A
Completed NCT05491746 - Diabetic Retinopathy Tethered Augmented Reality With Eye4 Study N/A
Completed NCT03728660 - Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System N/A
Completed NCT05209581 - Assessment of Visual Acuity in Refugee Population
Recruiting NCT01879501 - Living Successfully With Chronic Eye Diseases N/A